Joel A. Fernandes

54 year

Health Technology

Consumer Services

Electronic Technology

Profile

Joel A.
Fernandes formerly worked at Innoviva, Inc., as Associate Director-Finance from 2005 to 2006, Innoviva, Inc., as Associate Director-Finance, ALZA Corp., as Assistant Controller from 1999 to 2002, KLA Corp., as Senior Manager-Corporate Finance from 2002 to 2005, and Threshold Pharmaceuticals, Inc., as Senior Vice President-Finance & Controller.
Mr. Fernandes received his graduate degree from Manchester College.

Former positions of Joel A. Fernandes

Companies	Position	End
INNOVIVA, INC.	Corporate Officer/Principal	2006-02-28
KLA CORPORATION	Corporate Officer/Principal	2004-12-31
ALZA CORPORATION	Corporate Officer/Principal	2001-12-31
INNOVIVA, INC.	Corporate Officer/Principal	-
Threshold Pharmaceuticals, Inc. Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA	Director of Finance/CFO	-

See the detail of Joel A. Fernandes's experience

Training of Joel A. Fernandes

Manchester College

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joel A. Fernandes's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
INNOVIVA, INC.	Health Technology
KLA CORPORATION	Electronic Technology

Private companies	2
Threshold Pharmaceuticals, Inc. Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA	Health Technology
ALZA Corp. ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA.	Health Technology